Viracta Therapeutics Inc (VIRX) Free Cash Flow by Year
Viracta Therapeutics Inc recorded an outflow of $40.0M in free cash flow in fiscal year 2023. This represents a decrease of 12.8% from the prior fiscal year. The table below carries 15 fiscal years, from 2009 to 2023, and the quarters Viracta Therapeutics Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VIRX Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
VIRX Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Viracta Therapeutics Inc financials
Frequently Asked Questions
What was Viracta Therapeutics Inc's free cash flow in fiscal year 2023?
Viracta Therapeutics Inc recorded an outflow of $40.0M in free cash flow in fiscal year 2023.
How fast is Viracta Therapeutics Inc's free cash flow growing?
Viracta Therapeutics Inc (VIRX) free cash flow fell by 12.8% year over year, from -$35.5M to -$40.0M in fiscal year 2023.
How has Viracta Therapeutics Inc's free cash flow changed over the years?
Across the 15 fiscal years this page covers, Viracta Therapeutics Inc (VIRX) free cash flow went from -$20.2M in fiscal year 2009 to -$40.0M in fiscal year 2023.
What was Viracta Therapeutics Inc's free cash flow in the most recent quarter?
Viracta Therapeutics Inc (VIRX) reported -$7.1M in free cash flow in Q3 2024. This represents an increase of 33.0% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Viracta Therapeutics Inc (VIRX) reported on that line in every period on record.